Last reviewed · How we verify
NCT04345731
Over-the-counter (OTC) Labels for Older Adults
NA trial testing Over the counter drug labels in Adverse Drug Event in 420 participants. Completed in 16 December 2023.
16 December 2023
Quick facts
| Lead sponsor | Michigan State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 420 |
| Start date | 16 July 2018 |
| Primary completion | 16 December 2023 |
| Estimated completion | 16 December 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Over the counter drug labels
Conditions studied
- Adverse Drug Event — all drugs for Adverse Drug Event →
Sponsor
Michigan State University
Who can join
Adults 65 to 110, any sex, with Adverse Drug Event. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Optimizing OTC labels for older adults: Empirical evaluation of labels designed to provide older users the information they need to to minimize adverse drug events
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04345731
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adverse Drug Event
Currently open trials in the same condition.
- NCT06575530 — Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients · Phase 4 · recruiting
- NCT06498167 — Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib) · recruiting
- NCT07164300 — Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery · NA · recruiting
- NCT05084196 — Melatonin for Prevention of Kidney Injury · Phase 3 · recruiting
- NCT05717712 — Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma · Phase 1 · recruiting
Other Michigan State University trials
Trials by the same sponsor.
- NCT06325150 — The Impact of Light Exposure on Cognitive Function in Classrooms · Phase 1 · not yet recruiting
- NCT07213284 — Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial · NA · not yet recruiting
- NCT07164391 — Empowering Vietnamese Americans · NA · not yet recruiting
- NCT04521972 — Impact of Room Light on Uterine Contractions and Labor Progression in Pregnancy · NA · recruiting
- NCT05358964 — Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the Black Community · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04345731 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Michigan State University
- Last refreshed: 11 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04345731.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing